Showing results (381-390 of 785) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|October 11, 2020
Burden of living with HIV among men who have sex with men: a mixed-methods studyWard P H van Bilsen, Hanne M L Zimmermann, Anders Boyd, et al.
The Lancet. HIV|January 14, 2023
Effect of the introduction of screening for cancer precursor lesions on anal cancer incidence over time in people living with HIV: a nationwide cohort studyRamon P van der Zee, Ferdinand W N M Wit, Olivier Richel, et al.
The Lancet. HIV|December 2, 2022
Free HIV self-test for identification and linkage to care of previously undetected HIV infection in men who have sex with men in England and Wales (SELPHI): an open-label, internet-based, randomised controlled trialAlison J Rodger, Leanne McCabe, Andrew N Phillips, et al.
The Lancet. HIV|December 4, 2022
The effects of intimate partner violence on women's risk of HIV acquisition and engagement in the HIV treatment and care cascade: a pooled analysis of nationally representative surveys in sub-Saharan AfricaSalome Kuchukhidze, Dimitra Panagiotoglou, Marie-Claude Boily, et al.
The Lancet. HIV|November 25, 2022
Advanced HIV disease and health-related suffering-exploring the unmet need of palliative careAjay Rangaraj, Stephen Connor, Richard Harding, et al.
The Lancet. HIV|July 29, 2022
72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled studyThokozile R Malaba, Irene Nakatudde, Kenneth Kintu, et al.
The Lancet. HIV|July 29, 2022
Viral suppression and HIV-1 drug resistance 1 year after pragmatic transitioning to dolutegravir first-line therapy in Malawi: a prospective cohort studyBirgit Schramm, Elvis Temfack, Diane Descamps, et al.
The Lancet. HIV|July 29, 2022
Temporal changes in paediatric and adolescent HIV outcomes across the care continuum in Zambia: an interrupted time-series analysisCarolyn Bolton-Moore, Izukanji Sikazwe, Mwangelwa Mubiana-Mbewe, et al.
The Lancet. HIV|July 17, 2019
Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research prioritiesSharon Nachman, Claire L Townsend, Elaine J Abrams, et al.
The Lancet. HIV|April 15, 2024
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm studyCarina A Rodriguez, Eva Natukunda, Renate Strehlau, et al.
Pageof 79